日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proteomics analysis: inhibiting the expression of P62 protein by chloroquine combined with dacarbazine can reduce the malignant progression of uveal melanoma

蛋白质组学分析:氯喹联合达卡巴嗪抑制P62蛋白表达可降低葡萄膜黑色素瘤的恶性进展

Fei, Xifeng; Xie, Xiangtong; Qin, Ruwei; Wang, Anqi; Meng, Xuan; Sun, Fei; Zhao, Yifan; Jiang, Dongyi; Chen, Hanchun; Huang, Qiang; Ji, Xiaoyan; Wang, Zhimin

A Mass Spectrometry Based Metabolite Profiling Workflow for Selecting Abundant Specific Markers and Their Structurally Related Multi-Component Signatures in Traditional Chinese Medicine Multi-Herb Formulae

基于质谱的代谢物分析工作流程,用于选择中药多药方中丰富的特异性标记物及其结构相关的多组分特征

Joëlle Houriet, Pierre-Marie Allard, Emerson Ferreira Queiroz, Laurence Marcourt, Arnaud Gaudry, Lennie Vallin, Songhua Li, Yu Lin, Ruwei Wang, Kenny Kuchta, Jean-Luc Wolfender

Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol

建立胶质瘤干细胞诱导的恶性转化树突状细胞系SU3-ihDCTC,并研究其对白藜芦醇的敏感性

Fei, Xifeng; Wang, Anqi; Wang, Delin; Meng, Xan; Ma, Jiawei; Hong, Lei; Qin, Ruwei; Wang, Aidong; Dong, Jun; Huang, Qiang; Wang, Zhimin

RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion

携带 shPKM2 的 RGD 修饰溶瘤腺病毒通过抑制自噬和促进细胞凋亡在胰腺癌中表现出强大的细胞毒作用

Yanni Xu, Liang Chu, Sujing Yuan, Yuanqin Yang, Yu Yang, Bin Xu, Kangjian Zhang, Xin-Yuan Liu, Ruwei Wang, Ling Fang, Zhinan Chen, Zongsuo Liang

Combination of oncolytic adenovirus and luteolin exerts synergistic antitumor effects in colorectal cancer cells and a mouse model

溶瘤腺病毒与木犀草素的组合在结直肠癌细胞和小鼠模型中发挥协同抗肿瘤作用

Boduan Xiao, Yun Qin, Chang Ying, Buyun Ma, Binrong Wang, Fei Long, Ruwei Wang, Ling Fang, Yigang Wang